So pardon the pun – “where’s the meat and what’s the price going to be”!
Thus, my mission continues … saying the "things" that need to be said, not whispered by those in the "know"!
April 1, 2016
RegMed Investors (RMi) it’s time to act on subscription!
March 31, 2016
Biostage ™ hits the limelight with a quantified focus - BUY
March 28, 2016
Opexa Therapeutics (OPXA) ATM initiation
March 9, 2016
Vericel (VCEL) new debt burden inhibits valuation
March 7, 2016
Spark Therapeutics (ONCE) acquires Genable Technologies
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at firstname.lastname@example.org.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors